...

No Slide Title

by user

on
2

views

Report

Comments

Transcript

No Slide Title
R&D & TECHNOLOGY MANAGEMENT: APPROACH & STRATEGY
Setting up New R&D Models
IGIB has been very successful in setting up new business models for conducting R&D in its focus areas of research. Some
of the successfully adopted R&D models by the Institute are one of its kind and have never been adopted by any other
research Institute in India. One of the main R&D models adopted by the Institute in the recent past is “Genomed” – The
Knowledge alliance of IGIB - Nicolas Piramal. A brief description of the above mentioned model is as follows:
Setting up New R&D Models: “GENOMED” The IGIB-NPIL- KNOWLEDGE ALLIANCE
Genomed is a Knowledge alliance one of its kind, forged for the first time between an industrial concern - Nicholas Piramal
India Limited & a CSIR lab - Centre for Biochemical Technology (CBT) now IGIB, on 8-11-2000. It is based on a special
model where knowledge is the commodity (product). In this model knowledge evaluation has been done and knowledge has
been equated like EQUITY but in the form of IPR share for CBT/ IGIB. Some of the salient features of the alliance are:
• This knowledge alliance is dedicated to the study and advancement of Genomics, Pharmacogenomics and
Bioinformatics.
• It is a first-of-its-kind alliance in India between a Government owned Institute and a pharmaceutical company.
Novelty of Genomed:
Genomed model has allowed knowledge generation and absorption by industry, while simultaneously using
operating expenses of industrial partner, with very little capital investment from IGIB’s coffers. This is distinctly
different from contractual research or technology transfer. The projects under Genomed are developed jointly
using business driven R&D approach and are executed by Genomed scientists under the guidance of IGIB
scientists and Director IGIB, who is the chairperson of the Scientific Advisory Board of Genomed.
R&D & TECHNOLOGY MANAGEMENT: APPROACH & STRATEGY
Setting up New R&D Models : IGIB-
NPIL- Knowledge Alliance
Knowledge through generation
of ideas & formulation of
commercially viable R & D plan
for Genomic Medicine
Brings in finances, assets, H.R.
& management
IGIB (CSIR)
NPIL
(The R&D Institution)
JOINTLY MANAGED ADVISORY BOARD
• Provide technical services/ training.
• Provide spare capacity of facilities
• Following standard CSIR/Industry
contractual agreement.
• Evaluation of lab-scale processes
• Financial, Managerial & Infrastructure support
• Commitment to commercialization
GENOMED
(An Independent R&D Entity)
To Undertake Business Driven R & D
in Genomic Medicine
Fly UP